MicrobiologybioRxivPreprint
Inhibition of coronaviral exonuclease activity by TRIM-mediated SUMOylation
Kannan Balakrishnan, Surajit Chakraborty, Cindy Chiang…·Michaela Ulrike Gack
The paper identifies TRIM32 as an antiviral protein that inhibits SARS-CoV-2 replication by SUMOylating NSP14, thereby blocking its exonuclease activity.
2 citations